Why RTSM Software Doesn't Belong Inside An All-In-One Suite

By Ryan Keane, founder and CEO, Korio

The appeal of an “all-in-one” eClinical platform is undeniable: one contract, one login, and the promise of seamless integration. However, when highly technical components like Randomization and Trial Supply Management (RTSM) are treated as just another module in a generalized suite, the convenience often comes at the expense of performance. RTSM is not a "set it and forget it" feature; it is a technically complex, deeply regulated discipline that sits at the literal center of live study operations.

In many large suites, RTSM becomes a "checkbox" offering. Internal investment naturally flows toward higher-revenue drivers like EDC, leaving RTSM to fight for developer time and roadmap priority. This dilution of focus doesn't just slow innovation—it compromises expertise. As study designs become more adaptive and personalized, your RTSM needs to be engineered for flexibility, not just bundled for administrative ease. Choosing a purpose-built solution ensures that the operational backbone of your trial receives the singular focus it deserves.